Robin Sherrington's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Mar 8, 2024
- Accession no.
- 0000950170-24-028795
- Filed
- Mar 8, 2024
- Trade date
- Mar 7, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $330.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robin SherringtonCIK 0001619962 | Officer (EVP, Strategy & Innovation) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Shares | MOption exerciseAcquired | +1,234 | $9.85 | +$12,154.9 | 9,632 | Direct | |
| Mar 7, 2024 | Common Shares | FTax withholdingDisposed | −215 | $45.96 | −$9,881.4 | 9,417 | Direct | |
| Mar 7, 2024 | Common Shares | MOption exerciseAcquired | +7,407 | $9.85 | +$72,958.95 | 16,824 | Direct | |
| Mar 7, 2024 | Common Shares | FTax withholdingDisposed | −1,289 | $45.96 | −$59,242.44 | 15,535 | Direct | |
| Mar 7, 2024 | Common Shares | SSaleDisposed | −1,019 | $46.15 | −$47,026.85 | 14,516 | Direct | |
| Mar 7, 2024 | Common Shares | SSaleDisposed | −6,118 | $46.30 | −$283,263.4 | 8,398 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Shares | MOption exerciseDisposed | −1,234 | $0.00 | $0 | 0 | Direct | |
| Mar 7, 2024 | Common Shares | MOption exerciseDisposed | −7,407 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.